| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |